The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland.

Vesikansa, Aino; Mehtälä, Juha; Mutanen, Katja; Lundqvist, Annamari; Laatikainen, Tiina; Ylisaukko-Oja, Tero; Saukkonen, Tero; Pietiläinen, Kirsi H

Vesikansa, Aino; Mehtälä, Juha; Mutanen, Katja; Lundqvist, Annamari; Laatikainen, Tiina; Ylisaukko-Oja, Tero; Saukkonen, Tero; Pietiläinen, Kirsi H.

Afiliação

Vesikansa A; MedEngine Oy, Helsinki, Finland.
Mehtälä J; MedEngine Oy, Helsinki, Finland.
Mutanen K; Novo Nordisk Farma Oy, Espoo, Finland.
Lundqvist A; Finnish Institute for Health and Welfare, Helsinki, Finland.
Laatikainen T; Finnish Institute for Health and Welfare, Helsinki, Finland.
Ylisaukko-Oja T; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Saukkonen T; Joint Municipal Authority for North Karelia Social andHealth Services (Siun Sote), Joensuu, Finland.
Pietiläinen KH; MedEngine Oy, Helsinki, Finland.

J Mark Access Health Policy ; 11(1): 2166313, 2023.

Article em En | MEDLINE | ID: mdl-36684852

Palavras-chave

Body mass index; comorbidities; direct costs; healthcare costs; medication costs; metabolic syndrome; obesity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: J Mark Access Health Policy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google